Researchers at UC San Diego say they recently uncovered new insights into a protein that has emerged as a potential molecular “switch” that may determine whether Alzheimer’s-like brain changes lead to ...
The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop ...
Should you receive a diagnosis of AD, many factors shape how symptoms unfold. The brain, even when under siege, retains an ...
Some brains resist Alzheimer's, even when the disease is already present. Researchers at the Netherlands Institute for ...
A new study conducted by Indiana University School of Medicine researchers has found that primary care screenings for ...
Based on postmortem brain research, around 20 to 30 percent of older adults are thought to have asymptomatic Alzheimer's ...
A common blood test marker may reveal Alzheimer’s risk years in advance. Elevated immune cells could signal danger early and ...
Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...
A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
A study has revealed three types of cognitive decline in Alzheimer's disease -- stable or no change, slow decline, and fast ...
The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in ...
IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results